Stock Screener App

Frei -

Installieren

6.13

1.29% -0.08

after-market

Handel nachbörslich: 6.13

Kezar Life Sciences Inc (KZR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	18.24% 17.63	21.56	21.95	23.38	23.71
Operating Income/Loss	18.24% -17.63	-21.56	-21.95	-23.38	-23.71
Income/Loss From Continuing Operations Before Tax	18.11% -16.56	-20.22	-20.31	-21.55	-21.66
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	18.11% -16.56	-20.22	-20.31	-21.55	-21.66
Net Income/Loss	18.11% -16.56	-20.22	-20.31	-21.55	-21.66
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	222.77K% 7.3057	0.00328	7.2962	72.85	72.80
Diluted Average Shares	222.77K% 7.3057	0.00328	7.2962	72.85	72.80
Basic Earnings Per Share	18.05% -2.27	-2.77	-2.78	-0.30	-0.30
Diluted Earnings Per Share	18.05% -2.27	-2.77	-2.78	-0.30	-0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters